|
1
|
Kumar V, Abbas AK, Fausto N, et al:
Pathologic Basis of Disease. 8th ed. Elsevier Saunders;
Philadelphia, PA: pp. 710–711. 2009
|
|
2
|
Chiang TY, Shyu LY, Tsao TC, et al:
Elevated plasma matrix metalloproteinase-9 protein and its gene
polymorphism in patients with community-acquired pneumonia. Clin
Chem Lab Med. 50:449–454. 2011.PubMed/NCBI
|
|
3
|
Lee YT, Chen SC, Shyu LY, et al:
Significant elevation of plasma cathepsin B and cystatin C in
patients with community-acquired pneumonia. Clin Chim Acta.
413:630–635. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Houck PM, Bratzler DW, Nsa W, Ma A and
Bartlett JG: Timing of antibiotic administration and outcomes for
Medicare patients hospitalized with community-acquired pneumonia.
Arch Intern Med. 164:637–644. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ekman C, Gottsäter A, Lindblad B and
Dahlbäck B: Plasma concentrations of Gas6 and soluble Axl correlate
with disease and predict mortality in patients with critical limb
ischemia. Clin Biochem. 43:873–876. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ekman C, Linder A, Akesson P and Dahlbäck
B: Plasma concentrations of Gas6 (growth arrest specific protein 6)
and its soluble tyrosine kinase receptor sAxl in sepsis and
systemic inflammatory response syndromes. Crit Care. 14:R1582010.
View Article : Google Scholar
|
|
7
|
Hafizi S and Dahlbäck B: Gas6 and protein
S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase
subfamily. FEBS J. 273:5231–5244. 2006.PubMed/NCBI
|
|
8
|
Gheita TA, Bassyouni IH and Bassyouni RH:
Plasma concentrations of growth arrest specific protein 6 and the
soluble form of its tyrosine kinase receptor Axl in patients with
Systemic lupus erythematosus and Behçets disease. J Clin Immunol.
32:1279–1286. 2012.
|
|
9
|
Mandell LA, Wunderink RG, Anzueto A, et
al: Infectious Diseases Society of America/American Thoracic
Society consensus guidelines on the management ofcommunity-acquired
pneumonia in adults. Clin Infect Dis. 44:S27–S72. 2007. View Article : Google Scholar
|
|
10
|
Fine MJ, Auble TE, Yealy DM, et al: A
prediction rule to identify low-risk patients with
community-acquired pneumonia. N Engl J Med. 336:243–250. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Knaus WA, Draper EA, Wagner DP, et al:
APACHE II: a severity of disease classification system. Crit Care
Med. 13:818–829. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lim WS, van der Eerden MM, Laing R, et al:
Defining community acquired pneumonia severity on presentation to
hospital: an international derivation and validation study. Thorax.
58:377–382. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Melaragno MG, Wuthrich DA, Poppa V, et al:
Increased expression of Axl tyrosine kinase after vascular injury
and regulation by G protein-coupled receptor agonists in rats. Circ
Res. 83:697–704. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ekman C, Site DF, Gottsäter A, Lindblad B
and Dahlbäck B: Plasma concentrations of growth arrest specific
protein 6 and the soluble form of its tyrosine kinase receptor Axl
as markers of large abdominal aortic aneurysms. Clin Biochem.
43:110–114. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Robinson DR, Wu YM and Lin SF: The protein
tyrosine kinase family of the human genome. Oncogene. 19:5548–5557.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Linger RM, Keating AK, Earp HS and Graham
DK: TAM receptor tyrosine kinases: biologic functions, signaling,
and potential therapeutic targeting in human cancer. Adv Cancer
Res. 100:35–83. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Manfioletti G, Brancolini C, Avanzi G and
Schneider C: The protein encoded by a growth arrest-specific gene
(gas6) is a new member of the vitamin K dependent proteins related
to protein S, a negative coregulator in the blood coagulation
cascade. Mol Cell Biol. 13:4976–4985. 1993.
|
|
18
|
O’Bryan JP, Frye RA, Cogswell PC, et al:
Axl, a transforming gene isolated from primary human myeloid
leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell
Biol. 11:5016–5031. 1991.PubMed/NCBI
|
|
19
|
Vajkoczy P, Knyazev P, Kunkel A, et al:
Dominant-negative inhibition of the Axl receptor tyrosine kinase
suppresses brain tumor cell growth and invasion and prolongs
survival. Proc Natl Acad Sci USA. 103:5799–5804. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sawabu T, Seno H, Kawashima T, et al:
Growth arrest-specific gene 6 and Axl signaling enhances gastric
cancer cell survival via Akt pathway. Mol Carcinog. 46:155–164.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee IJ, Hilliard B, Swami A, et al: Growth
arrest-specific gene 6 (Gas6) levels are elevated in patients with
chronic renal failure. Nephrol Dial Transplant. 27:4166–4172. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ekman C, Jönsen A, Sturfelt G, Bengtsson
AA and Dahlbäck B: Plasma concentrations of Gas6 and sAxl correlate
with disease activity in systemic lupus erythematosus. Rheumatology
(Oxford). 50:1064–1069. 2011. View Article : Google Scholar : PubMed/NCBI
|
